Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen.

× No keyword cloud information.

57 in total

1. Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model.

Authors: Hong Wu; Zhihua Liu; Guoyu Ling; David Lawrence; Xinxin Ding
Journal: Toxicol Sci Date: 2013-07-24 Impact factor: 4.849

2. Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors: Erik S Carlson; Pramod Upadhyaya; Peter W Villalta; Bin Ma; Stephen S Hecht
Journal: Chem Res Toxicol Date: 2018-04-19 Impact factor: 3.739

3. Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.

Authors: Silvia Balbo; Charles S Johnson; Ramesh C Kovi; Sandra A James-Yi; M Gerard O'Sullivan; Mingyao Wang; Chap T Le; Samir S Khariwala; Pramod Upadhyaya; Stephen S Hecht
Journal: Carcinogenesis Date: 2014-09-30 Impact factor: 4.944

4. Genetic variation affects congenital heart defect susceptibility in offspring exposed to maternal tobacco use.

Authors: Xinyu Tang; Charlotte A Hobbs; Mario A Cleves; Stephen W Erickson; Stewart L MacLeod; Sadia Malik
Journal: Birth Defects Res A Clin Mol Teratol Date: 2015-06-02

5. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.

Authors: Jian-Min Yuan; Heather H Nelson; Steven G Carmella; Renwei Wang; Jacquelyn Kuriger-Laber; Aizhen Jin; Jennifer Adams-Haduch; Stephen S Hecht; Woon-Puay Koh; Sharon E Murphy
Journal: Carcinogenesis Date: 2017-04-01 Impact factor: 4.944

6. Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.

Authors: Xin Zhou; Jaime D'Agostino; Fang Xie; Xinxin Ding
Journal: J Pharmacol Exp Ther Date: 2012-01-19 Impact factor: 4.030

7. Effect of CYP2A13 active site mutation N297A on metabolism of coumarin and tobacco-specific nitrosamines.

Authors: Kari E Schlicht; Jeannette Zinggeler Berg; Sharon E Murphy
Journal: Drug Metab Dispos Date: 2008-12-12 Impact factor: 3.922

8. Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.

Authors: Jaime D'Agostino; Xiuling Zhang; Hong Wu; Guoyu Ling; Suping Wang; Qing-Yu Zhang; Fucai Liu; Xinxin Ding
Journal: Drug Metab Dispos Date: 2008-07-31 Impact factor: 3.922

9. The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract.

Authors: Jaime D'Agostino; Xiaoliang Zhuo; Mohammad Shadid; Daniel G Morgan; Xiuling Zhang; W Griffith Humphreys; Yue-Zhong Shu; Garold S Yost; Xinxin Ding
Journal: Drug Metab Dispos Date: 2009-07-16 Impact factor: 3.922

10. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors: Stephen Kalscheuer; Xiaoxiao Zhang; Yan Zeng; Pramod Upadhyaya
Journal: Carcinogenesis Date: 2008-09-09 Impact factor: 4.944